Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2002
08/28/2002CN1089784C Substituted quaterrylene tetracarboxylic acid diimides
08/28/2002CN1089765C 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
08/28/2002CN1089757C Process for producing aminonitropyridines
08/27/2002US6441174 Process for preparing bis(hydroxymethyl)perylenetetracarboximide
08/27/2002US6441169 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
08/27/2002US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid
08/27/2002US6440976 Iminopyrimidine NMDA NR2B receptor antagonists
08/27/2002US6440975 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
08/27/2002US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
08/27/2002US6440971 Binuclear complex
08/27/2002US6440956 Bicyclic polyaminoacid metal complexes, their process of preparation and their application in medical imaging
08/22/2002WO2002064843A1 Ecteinascidin family compounds: compositions and methods
08/22/2002WO2002064735A2 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
08/22/2002WO2002064680A1 Acid pigment dispersants and pigment preparations
08/22/2002WO2002064594A2 6-substituted pyrido-pyrimidines
08/22/2002WO2002064592A1 Tricyclic crf receptor antagonists
08/22/2002WO2002064591A2 Carboline derivatives
08/22/2002WO2002064590A2 Carboline derivatives
08/22/2002WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/22/2002WO2002064572A1 Quinazolines as mmp-13 inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064121A1 Novel modified released formulation
08/22/2002WO2002064119A1 Tablets quickly disintegrated in oral cavity
08/22/2002WO2002064118A1 Novel modified release formulation
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002WO2002048112A3 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
08/22/2002WO2002040471A3 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/22/2002WO2002030932A3 N8,n13-disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents
08/22/2002US20020115861 Process for preparing 1-substituted, 2-substituted 1H-imidazo [4, 5-c] quinoline-4-amines
08/22/2002US20020115854 Thrombin or factor Xa inhibitors
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
08/22/2002US20020115684 2, 7-naphthyridine derivatives
08/22/2002US20020115674 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
08/22/2002US20020115673 Preparation of risperidone
08/22/2002US20020115672 From 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole and 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a) pyrimidin-4-one; polymorphic forms
08/22/2002US20020115671 Inhibitors of p38-a kinase
08/22/2002US20020115663 Novel compounds
08/22/2002US20020115657 Such as 3-(4-(2-(10,11-dihydro-dibenzo(b,f)azepin-5-yl)-ethoxy)-phenyl)-2 -ethoxypropionic acid; for treatment/ prevention of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
08/22/2002US20020115652 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
08/22/2002US20020115566 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2437122A1 Quinazolines as mmp-13 inhibitors
08/22/2002CA2434835A1 Novel modified released formulation
08/22/2002CA2434542A1 Novel modified release formulation
08/22/2002CA2405532A1 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
08/21/2002CN1365361A Fused imiazole compounds and remedies for diabetes mellitus
08/21/2002CN1365356A Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
08/21/2002CN1365280A 抗菌化合物 Antibacterial compounds
08/20/2002US6437131 Process for preparing imidazoquinolinamines
08/20/2002US6437128 Cribrostatins 3-5
08/20/2002US6436962 Alpha 1a adrenergic receptor antagonists; relief from benign prostatic hyperplasia by less hindered urine flow by relaxing smooth muscle tissue; with a testosterone 5-alpha reductase inhibitor, finasteride; acute and chronic relief
08/20/2002US6436955 Storage stable, less hygroscopic, bactericide
08/20/2002US6436954 Benzo(b)quinolizidine and benzo(f)indolizidine derivatives useful for the treatment of alzheimer's disease, senile dementia or other conditions characterized by memory loss; pyrrolo(1,2-b)isoquinolines, benzo(b)quinolizines
08/20/2002US6436953 Antisecretory agents, gastrointestinal inflammatory diseases; (7r,8r,9r)-2,3-dimethyl-8-hydroxy-7-methoxy-9-phenyl-7,8,9,10-tetrahydro -imidazo(1,2-h)-(1,7)naphthyridine
08/20/2002US6436952 Cyclic nucleotide phosphodiesterase inhibitors; inflammatory airway disorders, such as asthma; antiinflammatory; 6-(4-(2h-2-ethyltetrazol-5-yl) phenyl)-1,2,3,4,4a,10b-hexahydrobenzo(c)(1,6)naohthyridine n-2-oxides
08/20/2002US6436951 Camptothecin tetracyclic analogues, preparation, method, applications as medicines and pharmaceutical compositions containing them
08/20/2002US6436949 Heterocyclically substituted benzamides and their use
08/20/2002US6436939 Treatment of central nervous system disorders including sleep/wake disorders, dementia, alzheimer's disease, epilepsy, narcolepsy, eating disorders, motion sickness, vertigo
08/20/2002US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives
08/20/2002CA2077695C Hydropyridine derivatives having antithrombotic activity
08/15/2002WO2002062800A1 Bicyclic nitrogenous fused-ring compound
08/15/2002WO2002062796A1 Epindolidione pigments
08/15/2002WO2002062795A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
08/15/2002WO2002062794A2 Compounds
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002062788A1 Sulfonamide compounds, their preparation and use
08/15/2002WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
08/15/2002WO2002062423A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
08/15/2002WO2002062340A1 Highly lipophilic camptothecin prodrugs, methods of preparation, and formulations thereof
08/15/2002WO2002062339A1 Antibacterial compounds
08/15/2002WO2002062315A1 Rapid-onset medicament for the treatment of sexual dysfunction
08/15/2002WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
08/15/2002WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/15/2002WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists
08/15/2002US20020111490 Certain pyrrolopyridine derivatives: novel CRF1 specific ligands
08/15/2002US20020111385 Synergistic mixtures
08/15/2002US20020111374 Estrogen receptor modulators
08/15/2002US20020111350 Aryl fused azapolycyclic compounds
08/15/2002US20020111344 Antidiabetic agetns, dietetics
08/15/2002US20020111343 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds
08/15/2002US20020111341 Bicyclic amino-pyrazinone compounds
08/15/2002US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators
08/15/2002CA2437215A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
08/15/2002CA2435546A1 Rapid-onset medicament for the treatment of sexual dysfunction
08/14/2002EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders
08/14/2002EP1230240A2 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists
08/14/2002EP1230235A1 Compounds with antibacterial and antiparasitic properties
08/14/2002EP1230225A2 Pharmaceutically active 4-substituted pyrimidine derivatives
08/14/2002EP1229910A1 Integrin receptor antagonists
08/14/2002EP1229907A1 Prevention of plaque rupture by acat inhibitors
08/14/2002EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002DE10106147A1 Saure Pigmentdispergatoren und Pigmentzubereitungen Acidic pigment dispersants and pigment preparations
08/13/2002US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
08/13/2002US6433174 Process for producing novel naphthyridine derivatives
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 646